We've found
21,509 Breast Cancer
clinical trials
We've found
21,509 Breast Cancer
clinical trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 7/19/2012
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/22/2013
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/22/2013
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/22/2013
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials

Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials

Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 7/7/2010
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Status: Enrolling
Updated: 7/7/2010
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 3/15/2011
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
Status: Enrolling
Updated: 3/15/2011
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 11/18/2013
Re-expression of ER in Triple Negative Breast Cancers
Status: Enrolling,
Phase
I, II
Updated: 11/18/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 1/14/2013
RO4929097 And Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Status: Enrolling
Updated: 1/14/2013
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/28/2012
Radiofrequency Ablation After Breast Lumpectomy (ABLATE)
Status: Enrolling
Updated: 12/28/2012
Click here to add this to my saved trials

Neoplasms, Breast Clinical Trial
Updated: 5/1/2014
Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer
Status: Enrolling
Updated: 5/1/2014
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 9/25/2012
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy
Status: Enrolling
Updated: 9/25/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/31/1969
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/31/1969
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/31/1969
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 5/27/2014
Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 5/27/2014
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 4/24/2013
ARQ197 in Metastatic Triple-Negative Breast Cancer
Status: Enrolling
Updated: 4/24/2013
Click here to add this to my saved trials

Metastatic Breast Cancer to the Brain Clinical Trial
Updated: 12/31/1969
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Metastatic Breast Cancer to the Brain Clinical Trial
Updated: 12/31/1969
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of LY3023414 in Participants With Advanced Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Neoplasms Clinical Trial
Updated: 12/31/1969
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Neoplasms Clinical Trial
Updated: 12/31/1969
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 3/30/2012
A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population
Status: Enrolling
Updated: 3/30/2012
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/24/2017
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/24/2017
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/24/2017
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/24/2017
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/24/2017
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/24/2017
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/31/1969
Pre-Operative Radiation and Veliparib for Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/14/2014
Single Fraction Intraoperative Radiotherapy
Status: Enrolling,
Phase
I, II
Updated: 10/14/2014
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Triciribine Phosphate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 2/2/2016
Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Breast Neoplasms Clinical Trial
Updated: 12/31/1969
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 9/23/2013
Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer
Status: Enrolling,
Phase
I
Updated: 9/23/2013
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 3/7/2014
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials
